—TDY
— • —
$651.96
P/E
34.54
PEG
—
FCF Yield
—
Rev Growth YoY
+611.0% YoY
Gross Margin
4276.0%
Health Score
6/10
D/E Ratio
0.24
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which limits full company-level context. Based on the financial profile — elevated valuation multiples, extraordinary reported margins, and a current share price of $651.96 — this appears to be a financially complex entity. Without a confirmed market capitalisation figure, the cap-tier classification cannot be reliably determined; the analysis proceeds on the available metrics only.
Financial Health
Score: 6/10
The balance sheet appears conservative, with a debt-to-equity ratio of just 0.24x, suggesting limited leverage risk. Reported gross margin of 4,276% and net margin of 1,463% are statistically anomalous and almost certainly reflect accounting distortions, one-time items, or a non-standard revenue recognition methodology — they should not be taken at face value as indicators of genuine operational profitability...
Risk Assessment
- DATA INTEGRITY: Gross margin of 4,276% and net margin of 1,463% are implausible for any conventional business and strongly suggest reporting anomalies or non-standard accounting that distorts financial analysis.
- EARNINGS DETERIORATION: Earnings growth of -88% YoY directly contradicts the 611% revenue growth, signalling either surging costs, margin compression at the operating level, or one-time revenue events that are not recurring.
- VALUATION PREMIUM: P/E of 34.54x sits approximately 38% above the sector average of 25x, with no DCF or PEG ratio to validate whether the premium is warranted.
- CASH FLOW OPACITY: Free cash flow is unavailable and the Python DCF flagged negative FCF as the reason for its failure to produce an estimate — a significant red flag for sustainability of operations.
- TECHNICAL DETERIORATION: A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates medium-term downward price momentum.
---...
**Score: 6/10** The balance sheet appears conservative, with a debt-to-equity ratio of just 0.24x, suggesting limited leverage risk. Reported gross margin of 4,276% and net margin of 1,463% are statistically anomalous and almost certainly reflect accounting distortions, one-time items, or a non-standard revenue recognition methodology — they should not be taken at face value as indicators of genuine operational profitability. Free cash flow data is unavailable, which prevents a reliable assessment of cash generation quality and is a meaningful transparency gap. ---
- **DATA INTEGRITY:** Gross margin of 4,276% and net margin of 1,463% are implausible for any conventional business and strongly suggest reporting anomalies or non-standard accounting that distorts financial analysis. - **EARNINGS DETERIORATION:** Earnings growth of -88% YoY directly contradicts the 611% revenue growth, signalling either surging costs, margin compression at the operating level, or one-time revenue events that are not recurring. - **VALUATION PREMIUM:** P/E of 34.54x sits approximately 38% above the sector average of 25x, with no DCF or PEG ratio to validate whether the premium is warranted. - **CASH FLOW OPACITY:** Free cash flow is unavailable and the Python DCF flagged negative FCF as the reason for its failure to produce an estimate — a significant red flag for sustainability of operations. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates medium-term downward price momentum. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives